Clinical trial
Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to…
NCT00439738 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00439738 |
|---|---|
| Title | Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults |
| Official title | A 16-week Double-blind, Randomized, Multicenter, Force-titration Study to Evaluate the Antihypertensive Efficacy of Valsartan/Hydrochlorothiazide (HCTZ) Therapy Compared to HCTZ Based Therapy in Obese, Hypertensive Patients |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | HCTZ + Amlodipine, Valsartan/HCTZ |
| Enrollment | 412 |
| Start date | Dec 1, 2006 |
| Primary completion | Nov 1, 2007 |
| First posted | Feb 26, 2007 |
| Last update posted | May 16, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: